News

QuickChek – May 21, 2021

Markets
0 min read


Onconova Therapeutics Announces The Initial Dosing Of The First Patient In The U.S. Phase 1 Clinical Trial Of ON 123300

Onconova announced that the first patient has been dosed in the U.S. Phase 1 clinical trial of ON 123300, the Company’s proprietary, novel multi-kinase inhibitor

Research, News & Market Data on Onconova

Watch recent presentation from NobleCon17



Aurania Reports Elevated Silver-Zinc Has Been Discovered In Outcrop Over 2.7 Kilometres At Tiria-Shimpia

Aurania Resources announced that follow-up of a high-grade boulder found in a stream has led to the discovery of silver-zinc mineralization

Research, News & Market Data on Aurania Resources

Watch recent presentation from NobleCon17



ProMIS Neurosciences re-initiates path to IND for PMN310 with producer cell line development

ProMIS Neurosciences announced PMN310 potential best in class antibody candidate for treatment of Alzheimer’s disease

Research, News & Market Data on ProMIS Neurosciences

Stay up to date. Follow us:

Share

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy